IP Library Granted Patent US 9,120,877
Granted Patent B2
US 9,120,877 · App. 13/002,363 · Granted Sep 1, 2015

Sulfated polysaccharide compound and the preparation and use thereof

Inventors: Vladimir Stajic (Alexandria, AU); Norman William Cheetham (Alexandria, AU); Alan Bell (Alexandria, AU)
Assignee: PARNELL TECHNOLOGIES PTY LTD
C08B37/0057C07H11/00C07H13/02C08B37/0003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,120,877
App. No.
13/002,363
Granted
Sep 1, 2015
Kind
B2
Abstract

The present invention relates to a sulfated polysaccharide compound and the preparation and use thereof, and in particular to a narrow distribution low molecular weight, highly sulfated pentosan (in this instance a xylan) referred to as glucuronoxylan sulfate (GXS). The invention has been developed primarily for use in the treatment of various clinical conditions. However, it will be appreciated that the invention is not restricted this particular field of use.

Claims (24)

1. A method for the production of sulfated glycan molecules, the method comprising:

(a) hydrolysis of xylan sulfates; followed by

(b) sulfation, wherein the sulfation results in xylan sulfates having an increased sulfur content of 17% to 21.9% based upon the weight of the sodium salt of the xylan sulfates.

2. A method for the production of sulfated glycan molecules, the method comprising:

(i) performing sulfation of xylan to provide partially sulfated xylan sulfates;

(ii) performing hydrolysis of the partially sulfated xylan sulfates to provide hydrolysed xylan sulfates;

(iii) performing sulfation of the hydrolysed xylan sulfates to provide xylan sulfates having an increased sulfur content of 17% to 21.9% based upon the weight of the sodium salt of the xylan sulfates.

3. A method for the production of sulfated glycan molecules, the method comprising:

(a) performing sulfation of xylan, by reaction with:

(i) pyridine chlorosulfonic acid complex in DMF;

(ii) pyridine SO 3 complex in DMF; or

(iii) a mixture of (i) and (ii) above,

to produce pyridinium xylan sulfates;

(b) replacing pyridinium with a counter ion to form non-pyridinium xylan sulfate salts, followed by removal of pyridinium and DMF;

(c) performing acid hydrolysis of the non-pyridinium xylan sulfate salts; and

(d) performing sulfation of the non-pyridinium xylan sulfate salts obtained following step (c) as described in step (a), followed by conversion to sodium salts and removal of the pyridine and DMF.

4. The method of claim 3 , further comprising performing ultrafiltration of the non-pyridinium xylan sulfate salts to remove inorganic impurities and degradation products.

5. The method of claim 3 , wherein the counter ion is an inorganic metal or an organic base.

6. The method of claim 4 , wherein the counter ion is an inorganic metal or an organic base.

7. The method of claim 1 , wherein the sulfated glycan molecules comprise one or more linear 1-4 conjugated beta-D-xylose units and at least one 4-O-methyl-beta-D-glucuronic acid unit attached to carbon-2 of every about eight to about ten xylose units.

8. The method of claim 2 , wherein the sulfated glycan molecules comprise one or more linear 1-4 conjugated beta-D-xylose units and at least one 4-O-methyl-beta-D-glucuronic acid unit attached to carbon-2 of every about eight to about ten xylose units.

9. The method of claim 3 , wherein the sulfated glycan molecules comprise one or more linear 1-4 conjugated beta-D-xylose units and at least one 4-O-methyl-beta-D-glucuronic acid unit attached to carbon-2 of every about eight to about ten xylose units.

10. The method of claim 1 , wherein in step (b) the sulfation results in xylan sulfates having 18% to 21.9% sulfur based upon the weight of the sodium salt of the xylan sulfates.

11. The method of claim 2 , wherein the xylan sulfates have 18% to 21.9% sulfur based upon the weight of the sodium salt of the xylan sulfates.

Assignments (13)
SECURITY INTEREST Recorded Dec 19, 2024
From: PARNELL TECHNOLOGIES PTY LTD
To: GLOBAL LOAN AGENCY SERVICES AUSTRALIA NOMINEES PTY LIMITED
Reel/Frame 069645/0640 →
RELEASE OF SECURITY INTEREST Recorded Dec 19, 2024
From: WHITE OAK HEALTHCARE FINANCE, LLC, AS AGENT
To: PARNELL TECHNOLOGIES PTY LTD
Reel/Frame 069645/0612 →
RELEASE OF SECURITY INTEREST Recorded Dec 22, 2020
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: PARNELL PHARMACEUTICALS HOLDINGS LTD; PARNELL TECHNOLOGIES PTY LTD; PARNELL MANUFACTURING PTY LTD; PARNELL PHARMACEUTICALS PTY LTD; PARNELL TECHNOLOGIES NZ PTY LTD; AUSTRALIAN PHARMA SERVICES PTY LTD; PARNELL CORPORATE SERVICES PTY LTD; PARNELL AUSTRALIA PTY LTD; PARNELL NORTH AMERICA PTY LTD; PARNELL EUROPE PTY LTD; PARNELL, INC.; PARNELL U.S. I, INC.; VETERINARY INVESTIGATIVE SERVICES, INC.; PARNELL NZ CO LIMITED; PARNELL CORPORATE SERVICES U.S., INC.
Reel/Frame 054718/0862 →
SECURITY INTEREST Recorded Dec 21, 2020
From: PARNELL TECHNOLOGIES PTY LTD
To: WHITE OAK HEALTHCARE FINANCE, LLC, AS AGENT
Reel/Frame 054706/0557 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2018
From: SWK FUNDING LLC
To: PARNELL PHARMACEUTICALS HOLDINGS LIMITED; PARNELL TECHNOLOGIES PTY LTD; PARNELL MANUFACTURING PTY LTD; PARNELL PHARMACEUTICALS PTY LTD; PARNELL TECHNOLOGIES NZ PTY LTD; AUSTRALIAN PHARMA SERVICES PTY LTD; PARNELL CORPORATE SERVICES PTY LTD; PARNELL AUSTRALIA PTY LTD; PARNELL NORTH AMERICA PTY LTD; PARNELL EUROPE PTY LTD; PARNELL TECHNOLOGIES (UK) LIMITED; PARNELL, INC.; PARNELL CORPORATE SERVICES U.S., INC.; PARNELL U.S. 1, INC.; VETERINARY INVESTIGATIVE SERVICES, INC.; PARNELL NZ CO LIMITED
Reel/Frame 046627/0992 →
SECURITY INTEREST Recorded Jul 31, 2018
From: PARNELL PHARMACEUTICALS HOLDINGS LIMITED; PARNELL TECHNOLOGIES PTY LTD; PARNELL MANUFACTURING PTY LTD; PARNELL PHARMACEUTICALS PTY LTD; PARNELL TECHNOLOGIES NZ PTY LTD; AUSTRALIAN PHARMA SERVICES PTY LTD; PARNELL CORPORATE SERVICES PTY LTD; PARNELL AUSTRALIA PTY LTD; PARNELL NORTH AMERICA PTY LTD; PARNELL EUROPE PTY LTD; PARNELL, INC.; PARNELL CORPORATE SERVICES U.S., INC.; PARNELL U.S. 1, INC.; VETERINARY INVESTIGATIVE SERVICES, INC.; PARNELL NZ CO LIMITED
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 046679/0300 →
SECURITY INTEREST Recorded Jul 31, 2018
From: PARNELL PHARMACEUTICALS HOLDINGS LIMITED; PARNELL TECHNOLOGIES PTY LTD; PARNELL MANUFACTURING PTY LTD; PARNELL PHARMACEUTICALS PTY LTD; PARNELL TECHNOLOGIES NZ PTY LTD; AUSTRALIAN PHARMA SERVICES PTY LTD; PARNELL CORPORATE SERVICES PTY LTD; PARNELL AUSTRALIA PTY LTD; PARNELL NORTH AMERICA PTY LTD; PARNELL EUROPE PTY LTD; PARNELL, INC.; PARNELL CORPORATE SERVICES U.S., INC.; PARNELL U.S. 1, INC.; VETERINARY INVESTIGATIVE SERVICES, INC.; PARNELL NZ CO LIMITED
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 046679/0210 →
RELEASE OF SECURITY INTEREST Recorded Dec 15, 2016
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: PARNELL PHARMACEUTICALS HOLDINGS LTD; PARNELL, INC.; PARNELL MANUFACTURING PTY LTD; PARNELL TECHNOLOGIES PTY LTD; PARNELL PHARMACEUTICALS PTY LTD; PARNELL TECHNOLOGIES NZ PTY LTD; AUSTRALIAN PHARMA SERVICES PTY LTD; PARNELL CORPORATE SERVICES PTY LTD; PARNELL AUSTRALIA PTY LTD; PARNELL NORTH AMERICA PTY LTD; PARNELL EUROPE PTY LTD; PARNELL CORPORATE SERVICES U.S., INC.; PARNELL U.S. 1, INC.; VETERINARY INVESTIGATIVE SERVICES, INC.
Reel/Frame 040940/0848 →
SECURITY INTEREST Recorded Dec 15, 2016
From: PARNELL, INC.; PARNELL CORPORATE SERVICES U.S., INC.; PARNELL U.S. 1, INC.; VETERINARY INVESTIGATIVE SERVICES, INC.; PARNELL PHARMACEUTICALS HOLDINGS LTD; PARNELL MANUFACTURING PTY LTD; PARNELL TECHNOLOGIES PTY LTD; PARNELL PHARMACEUTICALS PTY LTD; PARNELL TECHNOLOGIES NZ PTY LTD; AUSTRALIAN PHARMA SERVICES PTY LTD; PARNELL CORPORATE SERVICES PTY LTD; PARNELL AUSTRALIA PTY LTD; PARNELL NORTH AMERICA PTY LTD; PARNELL EUROPE PTY LTD; PARNELL NZ CO. LIMITED; PARNELL TECHNOLOGIES (UK) LIMITED
To: SWK FUNDING LLC
Reel/Frame 040987/0132 →
SECURITY INTEREST Recorded Jun 16, 2015
From: PARNELL TECHNOLOGIES PTY LTD
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 035919/0452 →
RELEASE OF SECURITY INTEREST Recorded Jun 11, 2015
From: SWK FUNDING LLC, AS AGENT
To: PARNELL PHARMACEUTICALS HOLDINGS PTY LTD; PARNELL, INC; PARNELL MANUFACTURING PTY LTD; PARNELL TECHNOLOGIES PTY LTD; PARNELL PHARMACEUTICALS PTY LTD; PARNELL TECHNOLOGIES NZ PTY LTD; AUSTRALIAN PHARMA SERVICES PTY LTD; PARNELL CORPORATE SERVICES PTY LTD; PARNELL AUSTRALIA PTY LTD; PARNELL NORTH AMERICA PTY LTD; PARNELL EUROPE PTY LTD; PARNELL NZ CO LIMITED; PARNELL TECHNOLOGIES (UK) LIMITED; PARNELL CORPORATION SERVICES U.S., INC.; PARNELL US 1, INC.; VETERINARY INVESTIGATIVE SERVICES, INC.
Reel/Frame 035890/0140 →
SECURITY AGREEMENT Recorded Feb 5, 2014
From: PARNELL PHARMACEUTICALS HOLDINGS PTY LTD; PARNELL, INC.; PARNELL MANUFACTURING PTY LTD; PARNELL TECHNOLOGIES PTY LTD; PARNELL PHARMACEUTICALS PTY LTD; PARNELL TECHNOLOGIES NZ PTY LTD; AUSTRALIAN PHARMA SERVICES PTY LTD; PARNELL CORPORATE SERVICES PTY LTD; PARNELL AUSTRALIA PTY LTD; PARNELL NORTH AMERICA PTY LTD; PARNELL EUROPE PTY LTD; PARNELL NZ CO LIMITED; PARNELL TECHNOLOGIES (UK) LIMITED; PARNELL CORPORATION SERVICES U.S., INC.; PARNELL U.S. 1, INC.; VETERINARY INVESTIGATIVE SERVICES, INC.
To: SWK FUNDING LLC, AS AGENT
Reel/Frame 032164/0070 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2011
From: STAJIC, VLADIMIR; CHEETHAM, NORMAN; BELL, ALAN
To: PARNELL TECHNOLOGIES PTY LTD
Reel/Frame 026494/0621 →
Priority Claims (1)
AU 2008903436 · Jul 4, 2008 · national
Continuity (1)
Related Publication 20110251154A1 · Oct 13, 2011